Antibody-mediated and ligand-mediated targeting of differentiati

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 858, 514 21, 436829, A61K 3722, A61K 966

Patent

active

052309002

ABSTRACT:
The present invention relates to compositions which mediate antibody and ligand targeting of differentiation-inducers to tumor cells and methods for employing the same.

REFERENCES:
patent: 4372949 (1983-02-01), Kodama et al.
patent: 4460560 (1984-07-01), Tokes et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4552812 (1985-11-01), Margel et al.
patent: 4674480 (1987-06-01), Lemelson
patent: 4764359 (1988-08-01), Lemelson
patent: 4806466 (1989-02-01), Papahadjopoulos et al.
patent: 4837028 (1989-06-01), Allen
patent: 4855090 (1989-08-01), Wallach
patent: 4920016 (1980-04-01), Allen et al.
patent: 5064823 (1991-11-01), Lee et al.
Kapil Mehta et al, "Induction of Tissue Transglutaminase in Human Peripheral Blood Monocytes by Intracellular Delivery of Retinoids", Journal of Leukocyte Biology, 41:341-348 (1987).
The Merck Index, 10th Ed., (Merck & Co., Inc., Rayway, N.J., 1983) p. 1057.
Otaka et al., "Antibody-Mediated Targeting of Differentiation Inducers to Tumor Cells: Inhibition of Colonic Cancer Cell Growth In Vitro and In Vivo", Biochemical and Biophysical Research Communications, vol. 158, No. 1, Jan. 16, 1989, pp. 202-208.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibody-mediated and ligand-mediated targeting of differentiati does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody-mediated and ligand-mediated targeting of differentiati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody-mediated and ligand-mediated targeting of differentiati will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2341077

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.